Anti-Ma2-associated encephalitis and paraneoplastic limbic encephalitis

Brain and Nerve

Volumn 62, Issue 8, 2010, Pages 838-851

  Yamamoto, Tomotaka ^a   Tsuji, Shoji ^a  

^a UNIVERSITY OF TOKYO HOSPITAL   (Japan)

Author keywords

Brainstem; Diencephalic; Encephalitis; Intratubular germ cell neoplasm; Limbic; Ma2; Onconeuronal; Paraneoplastic; Testis; Unclassified type

Indexed keywords

ANTIBODY; MA2 ANTIBODY; UNCLASSIFIED DRUG; AUTOANTIBODY; BIOLOGICAL MARKER; MA2 ANTIGEN; NERVE PROTEIN; TUMOR ANTIGEN;

ADULT; ARTICLE; BRAIN STEM; CANCER RISK; CARCINOMA IN SITU; CASE REPORT; CEREBELLUM; CEREBROSPINAL FLUID; CLINICAL FEATURE; DAYTIME SOMNOLENCE; DIENCEPHALON; ENCEPHALITIS; HUMAN; NERVE CELL; NEUROLOGIC DISEASE; OBSESSIVE COMPULSIVE DISORDER; PARANEOPLASTIC NEUROPATHY; TREATMENT RESPONSE; ANIMAL; BLOOD; DIFFERENTIAL DIAGNOSIS; FEMALE; IMMUNOLOGY; LIMBIC ENCEPHALITIS; LUNG TUMOR; MALE; MIDDLE AGED; NEOPLASM; NON SMALL CELL LUNG CANCER; PATHOPHYSIOLOGY; PROGNOSIS; TESTIS TUMOR;

ADULT; ANIMALS; ANTIGENS, NEOPLASM; AUTOANTIBODIES; BIOLOGICAL MARKERS; CARCINOMA, NON-SMALL-CELL LUNG; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LIMBIC ENCEPHALITIS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASMS, GERM CELL AND EMBRYONAL; NERVE TISSUE PROTEINS; PROGNOSIS; TESTICULAR NEOPLASMS;

EID: 77955783246     PISSN: 18816096     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Graus F, Delattre JY, Antoine JC, Dalmau J, Giometto B, et al: Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry, 75: 1135-1140, 2004
2. Graus F, Saiz A, Dalmau J: Antibodies and neuronal autoimmune disorders of the CNS. J Neurol 257: 509-517, 2009
3. Dalmau J, Graus F, Villarejo A, Posner JB, Blumenthal D, et al: Clinical analysis of anti-Ma2-associated encephalitis. Brain 127: 1831-1844, 2004
4. Mathew RM, Vandenberghe R, Garcia-Merino A, Yamamoto T, Landolfi JC, et al: Orchiectomy for suspected microscopic tumor in patients with anti-Ma2-associated encephalitis. Neurology 68: 900-905, 2007
5. Burton GV, Bullard DE, Walther PJ, Burger PC: Paraneoplastic limbic encephalopathy with testicular carcinoma. A reversible neurologic syndrome. Cancer 62: 2248-2251, 1988
6. ) Ahern GL, O'Connor M, Dalmau J, Coleman A, Posner JB, et al: Paraneoplastic temporal lobe epilepsy with testicular neoplasm and atypical amnesia. Neurology 44: 1270-1274, 1994
7. Dalmau J, Furneaux HM, Rosenblum MK, Graus F, Posner JB: Detection of the anti-Hu antibody in specific regions of the nervous system and tumor from patients with paraneoplastic encephalomyelitis/sensory neuronopathy. Neurology 41: 1757-1764, 1991
8. Gultekin SH, Voltz RD, Gerstner ER, Hoard RV, Posner JB, et al: Characterization of a Novel Antineuronal Antibody (Anti-Ta) in the Serum of 6 Patients with Testicular Cancer and Paraneoplastic Limbic Encephalopathy (PLE). Neurology 50 (Supple4): A383 (abstract), 1998
9. Voltz R, Gultekin SH, Rosenfeld MR, Gerstner E, Eichen J, et al: A serologic marker of paraneoplastic limbic and brain-stem encephalitis in patients with testicular cancer. N Engl J Med 340: 1788-1795, 1999
10. Dalmau J, Gultekin SH, Voltz R, Hoard R, DesChamps T, et al: Ma1, a novel neuron- and testis-specific protein, is recognized by the serum of patients with paraneoplastic neurological disorders. Brain 122 (Pt 1): 27-39, 1999
11. Schuller M, Jenne D, Voltz R: The human PNMA family: novel neuronal proteins implicated in paraneoplastic neurological disease. J Neuroimmunol 169: 172-176, 2005
12. Rosenfeld MR, Eichen JG, Wade DF, Posner JB, Dalmau J: Molecular and clinical diversity in paraneoplastic immunity to Ma proteins. Ann Neurol 50: 339-348, 2001
13. Giometto B, Grisold W, Vitaliani R, Graus F, Honnorat J, et al: Paraneoplastic neurologic syndrome in the PNS Euronetwork database: a European study from 20 centers. Arch Neurol 67: 330-335, 2010
14. Gultekin S, Rosenfeld M, Voltz R, Eichen J, Posner J, et al: Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain 123 (Pt 7): 1481-1494, 2000
15. Lancaster E, Lai M, Peng X, Hughes E, Constantinescu R, et al: Antibodies to the GABA (B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen. Lancet Neurol 9: 67-76, 2010
16. Graus F, Dalmou J, Rene R, Tora M, Malats N, et al: Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival. J Clin Oncol 15: 2866-2872, 1997
17. Monstad SE, Knudsen A, Salvesen HB, Aarseth JH, Vedeler CA: Onconeural antibodies in sera from patients with various types of tumours. Cancer Immunol Immunother 58: 1795-1800, 2009
18. Pittock SJ, Kryzer TJ, Lennon VA: Paraneoplastic antibodies coexist and predict cancer, not neurological syndrome. Ann Neurol 56: 715-719, 2004
19. Hoffmann LA, Jarius S, Pellkofer HL, Schueller M, Krumbholz M, et al: Anti-Ma and anti-Ta associated paraneoplastic neurological syndromes: 22 newly diagnosed patients and review of previous cases. J Neurol Neurosurg Psychiatry 79: 767-773, 2008
20. Mehta P, Fernando MM, Pickering MC, Wilson Y, Molloy S, et al: Lateral medullary syndrome with anti-neuronal antibodies (anti-Ta/Ma2) in primary Sjogren's syndrome. Rheumatology (Oxford) 48: 1174-1176, 2009
21. Desestret V, Didelot A, Meyronet D, Bruyas A, Jouvet A, et al: Neurosarcoidosis with diencephalitis and anti-Ma2 antibodies. Neurology 74: 772-774, 2010
22. Pruss H, Voltz R, Gelderblom H, Bohner G, Munz DL, et al: Spontaneous remission of anti-Ma associated paraneoplastic mesodiencephalic and brainstem encephalitis. J Neurol 255: 292-294, 2008
23. Matsumoto L, Yamamoto T, Higashihara M, Sugimoto I, Kowa H, et al: Severe hypokinesis caused by paraneoplastic anti-Ma2 encephalitis associated with bilateral intratubular germ-cell neoplasm of the testes. Mov Disord 22: 728-731, 2007
24. Psimaras D, Carpentier AF, Rossi C: Cerebrospinal fluid study in paraneoplastic syndromes. J Neurol Neurosurg Psychiatry 81: 42-45, 2010
25. Scheid R, Voltz R, Guthke T, Bauer J, Sammler D, et al: Neuropsychiatric findings in anti-Ma2-positive paraneoplastic limbic encephalitis. Neurology 61: 1159-1161, 2003
26. Landolfi JC, Nadkarni M: Paraneoplastic limbic encephalitis and possible narcolepsy in a patient with testicular cancer: case study. Neuro Oncol 5: 214-216, 2003
27. Kayser MS, Kohler CG, Dalmau J: Psychiatric Manifestations of Paraneoplastic Disorders. Am J Psychiatry, 2010 [Epub ahead of print]
28. Kerling F, Blumcke I, Stefan H: Pitfalls in diagnosing limbic encephalitis - a case report. Acta Neurol Scand 118: 339-342, 2008
29. Bennett JL, Galetta SL, Frohman LP, Mourelatos Z, Gultekin SH, et al: Neuro-ophthalmologic manifestations of a paraneoplastic syndrome and testicular carcinoma. Neurology 52: 864-867, 1999
30. Bataller L, Dalmau J: Neuro-ophthalmology and paraneoplastic syndromes. Curr Opin Neurol 17: 3-8, 2004
31. Castle J, Sakonju A, Dalmau J, Newman-Toker DE: Anti-Ma2-associated encephalitis with normal FDG-PET: a case of pseudo-Whipple's disease. Nat Clin Pract Neurol 2: 566-572; quiz 573, 2006
32. Saiz A, Bruna J, Stourac P, Vigliani MC, Giometto B, et al: Anti-Hu-associated brainstem encephalitis. J Neurol Neurosurg Psychiatry 80: 404-407, 2009
33. Pruss H, Voltz R, Flath B, Rudolph B, Klingebiel R, et al: Anti-Ta-associated paraneoplastic encephalitis with occult testicular intratubular germ-cell neoplasia. J Neurol Neurosurg Psychiatry 78: 651-652, 2007
34. Compta Y, Iranzo A, Santamaria J, Casamitjana R, Graus F: REM sleep behavior disorder and narcoleptic features in anti-Ma2-associated encephalitis. Sleep 30: 767-769, 2007 (Pubitemid 46854764)
35. Wagner J, Schankin C, Birnbaum T, Popperl G, Straube A: Ocular motor and lid apraxia as initial symptom of anti-Ma1/Ma2-associated encephalitis. Neurology 72: 466-467, 2009
36. Waragai M, Chiba A, Uchibori A, Fukushima T, Anno M, et al: Anti-Ma2 associated paraneoplastic neurological syndrome presenting as encephalitis and progressive muscular atrophy. J Neurol Neurosurg Psychiatry 77: 111-113, 2006
37. Dalmau J: Paraneoplastic disorders of the nervous system. Rinsho Shinkeigaku 48: 799-803, 2008
38. Tampoia M, Zucano A, Antico A, Giometto B, Bonaguri C, et al: Diagnostic accuracy of different immunological methods for the detection of antineuronal antibodies in paraneoplastic neurological syndromes. Immunol Invest 39: 186-195, 2010
39. Voltz R: Can antibodies in serum predict the presence of microscopic tumors? Neurology 68: 887-888, 2007
40. Stich O, Jarius S, Kleer B, Rasiah C, Voltz R, et al: Specific antibody index in cerebrospinal fluid from patients with central and peripheral paraneoplastic neurological syndromes. J Neuroimmunol 183: 220-224, 2007
41. Blumenthal DT, Salzman KL, Digre KB, Jensen RL, Dunson WA, et al: Early pathologic findings and long-term improvement in anti-Ma2-associated encephalitis. Neurology 67: 146-149, 2006
42. Basu S, Alavi A: Role of FDG-PET in the clinical management of paraneoplastic neurological syndrome: detection of the underlying malignancy and the brain PET-MRI correlates. Mol Imaging Biol 10: 131-137, 2008
43. Scheid R, Lincke T, Voltz R, von Cramon DY, Sabri O: Serial 18F-fluoro-2-deoxy-D-glucose positron emission tomography and magnetic resonance imaging of paraneoplastic limbic encephalitis. Arch Neurol 61: 1785-1789, 2004
44. Overeem S, Dalmau J, Bataller L, Nishino S, Mignot E, et al: Hypocretin-1 CSF levels in anti-Ma2 associated encephalitis. Neurology 62: 138-140, 2004
45. Jones TD, Ulbright TM, Eble JN, Cheng L: OCT4: A sensitive and specific biomarker for intratubular germ cell neoplasia of the testis. Clin Cancer Res 10: 8544-8547, 2004
46. van Casteren NJ, de Jong J, Stoop H, Steyerberg EW, de Bekker-Grob EW, et al: Evaluation of testicular biopsies for carcinoma in situ: immunohistochemistry is mandatory. Int J Androl 32: 666-674, 2008
47. Linke R, Schroeder M, Helmberger T, Voltz R: Antibody-positive paraneoplastic neurologic syndromes: value of CT and PET for tumor diagnosis. Neurology 63: 282-286, 2004
48. Younes-Mhenni S, Janier MF, Cinotti L, Antoine JC, Tronc F, et al: FDG-PET improves tumour detection in patients with paraneoplastic neurological syndromes. Brain 127: 2331-2338, 2004
49. Leyhe T, Schule R, Schwarzler F, Gasser T, Haarmeier T: Second primary tumor in anti-Ma1/2-positive paraneoplastic limbic encephalitis. J Neurooncol 78: 49-51, 2006
50. McKeon A, Apiwattanakul M, Lachance DH, Lennon VA, Mandrekar JN, et al: Positron emission tomography-computed tomography in paraneoplastic neurologic disorders: systematic analysis and review. Arch Neurol 67: 322-329, 2010
51. Vedeler CA, Antoine JC, Giometto B, Graus F, Grisold W, et al: Management of paraneoplastic neurological syndromes: report of an EFNS Task Force. Eur J Neurol 13: 682-690, 2006 (Pubitemid 44139368)
52. Sahashi K, Sakai K, Mano K, Hirose G: Anti-Ma2 antibody related paraneoplastic limbic/brain stem encephalitis associated with breast cancer expressing Ma1, Ma2, and Ma3 mRNAs. J Neurol Neurosurg Psychiatry 74: 1332-1335, 2003
53. Takaji M, Komatsu Y, Watakabe A, Hashikawa T, Yamamori T: Paraneoplastic antigen-like 5 gene (PNMA5) is preferentially expressed in the association areas in a primate specific manner. Cereb Cortex 19: 2865-2879, 2009
54. Wen PY: Cerebral spinal fluid abnormalities in patients with paraneoplastic syndromes of the nervous system. J Neurol Neurosurg Psychiatry 81: 3, 2010
55. Hill KE, Clawson SA, Rose JW, Carlson NG, Greenlee J E: Cerebellar Purkinje cells incorporate immunoglobulins and immunotoxins in vitro: implications for human neurological disease and immunotherapeutics. J Neuroinflammation 6: 31, 2009
56. Pellkofer H, Schubart AS, Hoftberger R, Schutze N, Pagany M, et al: Modelling paraneoplastic CNS disease: T-cells specific for the onconeuronal antigen PNMA1 mediate autoimmune encephalomyelitis in the rat. Brain 127: 1822-1830, 2004
57. Dalmau J, Rosenfeld MR: Paraneoplastic syndromes of the CNS. Lancet Neurol 7: 327-340, 2008
58. Kimura M, Onozawa M, Fujisaki A, Arakawa T, Takeda K, et al: Anti-Ma2 paraneoplastic encephalitis associated with testicular germ cell tumor treated by carboplatin, etoposide and bleomycin. Int J Urol 15: 942-943, 2008